Cosan S.A ADR's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Cosan S.A ADR reported revenue of $40.4B (-8.0% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net sales | $40.4B | $44.0B | $39.5B | — |
| Cost of sales | ($27.2B) | ($30.2B) | ($28.5B) | — |
| Gross profit | $13.2B | $13.7B | $10.9B | — |
| Selling expenses | ($1.9B) | ($1.6B) | ($1.4B) | — |
| General and administrative expenses | ($2.5B) | ($2.8B) | ($2.5B) | — |
| Other operating income (expenses), net | $3.2B | $1.5B | — | — |
| Impairment | ($1.5B) | ($3.2B) | — | — |
| Operating expenses | ($2.7B) | ($6.0B) | $45.8M | — |
| Profit before equity in earnings of investees, finance results and income taxes | $10.5B | $7.7B | $11.0B | — |
| Interest in earnings of associates | $219.9M | $1.7B | — | — |
| Interest in (losses) earnings of joint ventures | ($10.9B) | ($1.2B) | — | — |
| Equity in (losses) earnings of investees | ($10.7B) | ($4.2B) | — | — |
| Finance expense | ($8.9B) | ($7.6B) | — | — |
| Finance income | $3.6B | $2.7B | — | — |
| Foreign exchange, net | $2.4B | ($5.7B) | — | — |
| Net effect of derivatives | ($4.8B) | $2.0B | — | — |
| Finance results, net | ($7.8B) | ($8.7B) | — | — |
| (Loss) profit before income taxes | ($8.0B) | ($5.2B) | — | — |
| Current | ($1.3B) | ($2.0B) | — | — |
| Deferred | ($916.8M) | ($1.2B) | — | — |
| Income taxes | ($2.2B) | ($3.2B) | — | — |
| (Loss) profit for the year from continued operations | ($10.2B) | ($8.4B) | — | — |
| Remeasurement gain on defined benefit plans | $2.5M | $162.6M | — | — |
| Loss in fair value of financial liabilities designated at fair value through profit or loss attributable to changes in credit risk | ($89.3M) | — | — | — |
| Income tax impact | $25.7M | — | — | — |
| Items that will never be reclassified to profit or loss | ($61.0M) | $107.3M | — | — |
| Foreign currency translation differences | ($55.0M) | $537.1M | — | — |
| Gain (loss) on cash flow hedge | $242.3M | ($393.7M) | — | — |
| Income tax impact | ($42.0M) | — | — | — |
| Items that are or may be reclassified subsequently to profit or loss | $145.2M | $143.5M | — | — |
| Total other comprehensive income (loss), net of tax | $84.2M | $250.8M | — | — |
| Comprehensive (loss) income from continued operations | ($10.1B) | ($8.2B) | — | — |
| Owners of the Company | ($9.7B) | ($9.4B) | — | — |
| Non-controlling interests | ($472.3M) | $1.3B | — | — |
| (Loss) profit for the year | ($10.2B) | ($8.2B) | — | — |
| Owners of the Company | ($9.6B) | ($9.2B) | — | — |
| Non-controlling interests | ($462.8M) | $1.3B | — | — |
| Total comprehensive (loss) income for the year | ($10.1B) | ($7.9B) | — | — |
| Basic | -$3.89 | -$5.16 | — | — |
| Diluted | -$3.94 | -$5.16 | — | — |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $27.2B | $16.9B | $14.7B | $13.3B |
| Restricted cash | $45.8M | $28.0M | $7.9M | $8.0M |
| Marketable securities | $2.6B | $3.3B | $3.4B | $2.4B |
| Trade receivables | $3.5B | $3.7B | $3.3B | $3.8B |
| Derivative financial instruments | $311.0M | $905.3M | $202.4M | $1.1B |
| Inventories | $2.0B | $2.1B | $1.8B | $1.9B |
| Receivables from related parties | $199.5M | $197.1M | $251.5M | $235.5M |
| Income tax receivable | $1.2B | $793.7M | $888.9M | $560.8M |
| Other current tax receivable | $1.0B | $886.1M | $745.9M | $1.3B |
| Dividend receivable | $35.4M | $153.5M | $255.8M | $161.1M |
| Sectorial financial assets | $338.3M | $221.9M | $207.0M | $149.0M |
| Other financial assets | $612.0K | $675.0K | $690.0K | $89.0M |
| Other current assets | $993.7M | $629.4M | $722.4M | $560.1M |
| Total current assets before held for sale | $39.4B | $29.8B | $26.5B | $25.5B |
| Current assets held for sale | $652.2M | $978.8M | $2.1B | $40.4M |
| Total current assets | $40.1B | $30.8B | $28.6B | $25.6B |
| Trade receivables | $148.9M | $265.4M | $114.1M | $157.6M |
| Marketable securities | $404.2M | $113.4M | $96.0M | $19.7B |
| Restricted cash | $183.0M | $146.3M | $195.4M | $131.9M |
| Deferred tax assets | $3.7B | $4.5B | $5.6B | $4.5B |
| Receivables from related parties | $20.3M | $202.8M | $88.6M | $241.0M |
| Income tax receivable | $195.8M | $264.3M | $432.4M | $434.9M |
| Other non-current tax receivable | $1.8B | $1.3B | $1.1B | $1.1B |
| Judicial deposits | $1.1B | $1.1B | $895.9M | $814.4M |
| Derivative financial instruments | $2.0B | $2.9B | $2.3B | $3.1B |
| Sectorial financial assets | $390.6M | $509.7M | $341.7M | $193.4M |
| Other non-current assets | $919.7M | $739.4M | $216.7M | $201.8M |
| Other financial assets | $5.2M | $3.8M | $2.4M | $277.0K |
| Investment in associates | $1.7B | $10.7B | — | — |
| Investment in joint ventures | $60.4M | $10.5B | $11.7B | $11.2B |
| Property, plant and equipment | $26.8B | $23.0B | $21.2B | $18.9B |
| Intangible assets and goodwill | $26.7B | $26.3B | $22.7B | $22.1B |
| Contract assets | $1.0B | $1.1B | $1.1B | $1.1B |
| Right-of-use assets | $9.7B | $10.0B | $9.5B | $8.0B |
| Investment property | $18.2B | $16.8B | $16.0B | $14.1B |
| Non-current assets | $95.0B | $110.5B | $111.3B | $108.9B |
| Total assets | $135.1B | $141.3B | $139.9B | $134.5B |
| Loans, borrowings and debentures | $3.9B | $4.4B | $4.9B | $4.5B |
| Leases | $983.0M | $1.0B | $733.1M | $550.5M |
| Derivative financial instruments | $1.9B | $2.5B | $1.3B | $1.0B |
| Trade payables | $4.1B | $5.2B | $3.9B | $4.3B |
| Employee benefits payables | $771.6M | $794.9M | $829.3M | $659.5M |
| Income tax payables | $153.3M | $414.8M | $445.9M | $204.4M |
| Other taxes payable | $525.2M | $637.8M | $673.7M | $760.0M |
| Dividends payable | $226.5M | $96.7M | $549.1M | $892.0M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| (Loss) profit before income taxes | ($8.0B) | ($5.2B) | $5.1B | — |
| Depreciation and amortization | $3.9B | $3.9B | $3.4B | — |
| Impairment | $1.5B | $3.2B | — | — |
| Interest in earnings (losses) of subsidiaries and associates | ($219.9M) | ($1.7B) | — | — |
| Interest in earnings (losses) of joint ventures | $10.9B | $1.2B | ($1.7B) | — |
| Loss (gain) on disposed assets | $99.3M | ($141.9M) | $17.0M | — |
| Share-based payment | $71.7M | $65.9M | $207.7M | — |
| Change in fair value of investment properties | ($1.4B) | ($1.3B) | ($2.3B) | — |
| Provision for legal proceedings | $333.7M | $313.9M | $204.2M | — |
| Interest, derivatives, monetary and foreign exchange, net | $9.8B | $10.2B | $9.4B | — |
| Sectorial financial assets and liabilities, net | $116.5M | ($37.1M) | ($110.1M) | — |
| Provisions for employee benefits | $465.5M | $454.9M | $419.2M | — |
| Allowance for expected credit losses | $44.5M | $52.8M | $74.7M | — |
| Profit on sale of investment | ($32.4M) | $383.2M | — | — |
| Revenue from insurance claims | ($940.6M) | — | — | — |
| Income from finance investments | ($9.1M) | — | ($1.3B) | — |
| Previously recognized gain in other comprehensive income reclassified to profit | ($206.4M) | — | — | — |
| Other | ($79.3M) | ($261.3M) | $278.4M | — |
| Cash flows from operating activities before changes in working capital | $16.3B | $15.7B | $12.7B | — |
| Trade receivable | $539.7M | $546.2M | $573.7M | — |
| Inventories | ($107.8M) | $159.7M | ($83.2M) | — |
| Other taxes, net | ($921.0M) | ($354.4M) | $454.9M | — |
| Income taxes paid | ($1.2B) | ($1.5B) | ($1.3B) | — |
| Related parties, net | ($128.3M) | $105.5M | ($188.8M) | — |
| Trade payables | ($246.6M) | ($180.9M) | ($252.8M) | — |
| Employee benefits | ($515.5M) | ($542.2M) | ($356.2M) | — |
| Provision for legal proceedings | ($319.8M) | ($305.3M) | ($461.6M) | — |
| Derivative financial instruments | ($48.8M) | ($9.2M) | $2.9M | — |
| Other financial liabilities | $75.1M | ($26.3M) | ($566.1M) | — |
| Judicial deposits | ($36.7M) | ($149.1M) | ($22.9M) | — |
| Post-employment benefit obligation | ($42.9M) | ($37.5M) | ($34.2M) | — |
| Other assets and liabilities, net | ($250.1M) | ($372.4M) | ($244.3M) | — |
| Changes in working capital | ($3.2B) | ($2.7B) | ($2.5B) | — |
| Net cash generated from operating activities | $13.0B | $13.1B | $10.3B | — |
| Capital contribution to associates | ($15.7M) | ($30.0M) | — | — |
| Capital reduction in associates | $26.5M | — | — | — |
| Acquisition of subsidiary, net of acquired cash | ($615.6M) | ($962.4M) | ($47.3M) | — |
| Sale (purchase) of marketable securities, net | $988.9M | $551.0M | ($508.0M) | — |
| Restricted cash | ($56.8M) | $42.0M | ($60.5M) | — |
| Dividends received from subsidiaries and associates | $107.4M | $1.0B | $254.9M | — |
| Dividends received from joint venture | $45.6M | $293.9M | $906.5M | — |
| Dividends received from finance investment | $87.6M | — | $1.3B | — |
| Other financial assets | ($134.0K) | — | — | — |
| Acquisition of property, plant and equipment, intangible and contract assets | ($8.5B) | ($7.8B) | ($6.3B) | — |
| Proceeds from the sale of investments | $8.9B | $2.7B | $645.8M | — |
Cosan S.A ADR score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.